Website for further information
Bain Capital and Cinven published further information about the offer at their website www.niddahealthcare-offer.com.
We cannot assume any liability for the content and accuracy of the information provided.
Statement on the Public Delisting Tender Offer
Extraordinary General Meeting February 2, 2018
Here you will find all documents and information on the Extraordinary General Meeting on February 2, 2018.
to the documents
Listen to a recording of our journalists' call (in German)
August 21, 2017, 10.30 Uhr am (CEST)
Listen to a recording of our analysts' call
August 21, 2017, 11.30 Uhr am (CEST)
Letter from the Advisory Board to the Shareholders
Letter from the CEO to the Shareholders
- August 8, 2017: Personal letter from the Chairman of the Executive Board at STADA Arzneimittel AG Engelbert Coster Tjeenk Willink
- August 18, 2017: Investor News renewed offer acceptance rate (PDF)
- August 18, 2017: Investor News Minimum acceptance threshold for STADA takeover by Bain Capital and Cinven reached (PDF)
- August 18, 2017: FAQ – Frequently asked questions about the Takeover Offer by Bain Capital and Cinven (PDF)
- July 25, 2017: Joint Reasoned Statement of Management Board and Supervisory Board of STADA (PDF)
- July 25, 2017: Investor News Reasoned Joint Statement (PDF)
- July 19, 2017: Investor News Information on Takeover Offer (PDF)
- July 10, 2017: Ad-hoc-Release to the request for consent for the submission of a takeover offer (PDF)
Analysts' Call of July 10, 2017
Archive of the initial and expired takeover offer
The information on the initial and expired takeover offer of April 27, 2017 can be found in the archive.